(Q53940934)

22 May 2018

title

Hydralazine-induced vasodilation involves opening of high conductance Ca2+-activated K+ channels. (English)

1 reference

22 May 2018

author name string

L Bang

1

1 reference

22 May 2018

J E Nielsen-Kudsk

2

1 reference

22 May 2018

N Gruhn

3

1 reference

22 May 2018

S Trautner

4

1 reference

22 May 2018

S A Theilgaard

5

1 reference

22 May 2018

S P Olesen

6

1 reference

22 May 2018

S Boesgaard

7

1 reference

22 May 2018

J Aldershvile

8

1 reference

22 May 2018

language of work or name

English

0 references

publication date

1 November 1998

1 reference

22 May 2018

European Journal of Pharmacology

number of pages

7

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

22 May 2018

volume

361

1 reference

22 May 2018

issue

1

1 reference

22 May 2018

page(s)

43-49

1 reference

22 May 2018

Concurrent hydralazine administration prevents nitroglycerin-induced hemodynamic tolerance in experimental heart failure

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900701-8

Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900701-8

Regulation of arterial tone by activation of calcium-dependent potassium channels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900701-8

Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900701-8

A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900701-8

Modulation of single Ca2+-dependent K+-channel activity by protein phosphorylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900701-8

Prevention of tolerance to hemodynamic effects of nitrates with concomitant use of hydralazine in patients with chronic heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900701-8

Inhibition of calcium release from the sarcoplasmic reticulum of rabbit aorta by hydralazine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900701-8

Hydralazine prevents nitroglycerin tolerance by inhibiting activation of a membrane-bound NADH oxidase. A new action for an old drug

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900701-8

Physiological roles and properties of potassium channels in arterial smooth muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900701-8

A strain-gauge myograph for isometric measurements of tension in isolated small blood vessels and other muscle preparations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900701-8

K+ channel opening: a new drug principle in cardiovascular medicine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900701-8

Effects of K+ channel blockers on the relaxant action of dihydralazine, cromakalim and nitroprusside in isolated rabbit femoral arteries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900701-8

10.1016/S0014-2999(98)00701-8

7 January 2021

Identifiers

DOI

1 reference

22 May 2018

1 reference

22 May 2018